VF
EVOK

Virtu Financial’s Evoke Pharma EVOK Stock Holding History

Virtu Financial’s Portfolio EVOK Stock Details EVOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-297
Closed -$21K – 1719
2022
Q1 		$21K Sell
297
-87
-23% -$6.94K ﹤0.01% 1290
2021
Q4 		$31K Buy
384
+253
+193% +$35.4K ﹤0.01% 1439
2021
Q3 		$25K Buy
+131
New +$22.1K ﹤0.01% 1368
2021
Q1 		– Sell
-127
Closed -$47K – 1721
2020
Q4 		$47K Buy
+127
New +$65.5K 0.01% 1241
2019
Q4 		$70K Buy
+300
New +$51.4K 0.01% 1148
2019
Q3 		– Sell
-746
Closed -$67K – 1515
2019
Q2 		$67K Buy
746
+199
+36% +$19.7K ﹤0.01% 1198
2019
Q1 		$118K Buy
+547
New +$187K 0.01% 1106
2018
Q4 		– Sell
-185
Closed -$80K – 1669
2018
Q3 		$80K Buy
185
+76
+70% +$30.3K ﹤0.01% 1238
2018
Q2 		$39K Buy
+109
New +$40.9K ﹤0.01% 1797
2018
Q1 		– Sell
-149
Closed -$48K – 2130
2017
Q4 		$48K Sell
149
-125
-46% -$51.8K ﹤0.01% 2082
2017
Q3 		$132K Buy
+274
New +$106K 0.01% 2005

Other funds holding EVOK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Virtu Financial's EVOK Position: Q2 2022 in Review

Virtu Financial sold out of Evoke Pharma (EVOK) in Q2 2022, closing a stake of 297 shares — an estimated $21K sold.

Virtu Financial first reported a position in EVOK in Q3 2017 and held it in 11 quarters. The position peaked at $132K in Q3 2017. 12 funds tracked by Wall St. Rank hold EVOK as of Q2 2022.

  • Virtu Financial reported no remaining Evoke Pharma position as of Q2 2022 after selling out during the quarter.
  • Virtu Financial sold 297 Evoke Pharma shares in Q2 2022, an estimated $21K.
  • Virtu Financial first reported a position in Evoke Pharma in Q3 2017 and held it in 11 quarters.
  • Virtu Financial's Evoke Pharma position peaked at $132K in Q3 2017.
  • 12 funds tracked by Wall St. Rank held Evoke Pharma as of Q2 2022.

Based on Virtu Financial's 13F filing for Q2 2022, filed 9 Aug 2022.